Publication Date
March 2024
USD 67.39 billion
USD 237.70 billion
USD 80.62 billion
Auto-Injectors Market by Therapy (Anaphylaxis, Diabetes, Multiple Sclerosis), Product Type (Disposable Auto-Injectors, Reusable Auto-Injectors), Application, End-user - Global Forecast 2024-2030

[180 Pages Report] The Auto-Injectors Market size was estimated at USD 67.39 billion in 2023 and expected to reach USD 80.62 billion in 2024, at a CAGR 19.72% to reach USD 237.70 billion by 2030.

Auto-Injectors Market
To learn more about this report, request a free sample copy
The market for auto-injectors refers to the industry that designs, manufactures, and distributes devices used to deliver doses of medication automatically into the body. These devices are spring-loaded syringes used for the self-administration of drugs, including life-saving treatments for conditions such as severe allergic reactions (anaphylaxis), multiple sclerosis, rheumatoid arthritis, and others. They are highly valued for their ease of use, portability, and their ability to provide quick medical intervention. The auto-injector market is primarily driven by the prevalence of chronic diseases such as anaphylaxis and diabetes, which necessitate emergency medication administration. Moreover, technological advancements have contributed to developing more user-friendly auto-injectors, thus increasing their adoption. Enhanced awareness about severe allergy management and the convenience of self-administering life-saving drugs in case of emergencies also bolster the market's growth. However, challenges such as security concerns over data transmission, limited battery life of wireless sensors, and interoperability issues across different platforms and standards may impede market expansion. There is a significant opportunity in the auto-injectors market for companies that invest in research & development to create products with longer shelf lives, smaller sizes, and more convenient handling. The trend toward personalized medicine and biologics requiring precise dosing provides a fertile ground for market expansion. Furthermore, expanding into emerging markets with untapped potential due to growing healthcare infrastructure and increasing income levels could be highly beneficial for auto-injector manufacturers.
Auto-Injectors Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Auto-Injectors Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Auto-Injectors Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Auto-Injectors Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amgen Inc., Antares Pharma, Inc., AstraZeneca PLC, Bayer AG, Becton, Dickinson and Company, Biogen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Harro Höfliger Verpackungsmaschinen GmbH, Johnson & Johnson Services, Inc., Medeca Pharma AB, Merck KGaA, Mylan N.V. by Viatris Inc., NEMERA Group, Novartis AG, Pfizer, Inc., Ravimed Sp. z o.o., Recipharm AB, Sanofi S.A., SHL Medical AG, Stevanato Group, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Auto-Injectors Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Therapy
    • Anaphylaxis
    • Diabetes
    • Multiple Sclerosis
    • Rheumatoid Arthritis
  • Product Type
    • Disposable Auto-Injectors
    • Reusable Auto-Injectors
      • Empty
      • Prefilled
  • Application
    • Anaphylaxis
    • Anemia
    • Cardiovascular Diseases
    • Diabetes
    • Migraines
    • Multiple Sclerosis
    • Psoriasis
    • Rheumatoid Arthritis
  • End-user
    • Ambulatory Surgical Centers
    • Homecare Settings
    • Hospitals & Clinics

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Auto-Injectors Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Auto-Injectors Market?
  3. What are the technology trends and regulatory frameworks in the Auto-Injectors Market?
  4. What is the market share of the leading vendors in the Auto-Injectors Market?
  5. Which modes and strategic moves are suitable for entering the Auto-Injectors Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Auto-Injectors Market, by Therapy
  7. Auto-Injectors Market, by Product Type
  8. Auto-Injectors Market, by Application
  9. Auto-Injectors Market, by End-user
  10. Americas Auto-Injectors Market
  11. Asia-Pacific Auto-Injectors Market
  12. Europe, Middle East & Africa Auto-Injectors Market
  13. Competitive Landscape
  14. Competitive Portfolio
Companies Mentioned
  • AbbVie Inc.
  • Amgen Inc.
  • Antares Pharma, Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Becton, Dickinson and Company
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Harro Höfliger Verpackungsmaschinen GmbH
  • Johnson & Johnson Services, Inc.
  • Medeca Pharma AB
  • Merck KGaA
  • Mylan N.V. by Viatris Inc.
  • NEMERA Group
  • Novartis AG
  • Pfizer, Inc.
  • Ravimed Sp. z o.o.
  • Recipharm AB
  • Sanofi S.A.
  • SHL Medical AG
  • Stevanato Group
  • Teva Pharmaceutical Industries Ltd.
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Auto-Injectors Market
The Global Auto-Injectors Market size was estimated at USD 67.39 billion in 2023 and expected to reach USD 80.62 billion in 2024.
The Global Auto-Injectors Market to grow USD 237.70 billion by 2030, at a CAGR of 19.72%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.